Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation

被引:20
作者
Debenham, John S. [1 ]
Madsen-Duggan, Christina B. [1 ]
Wang, Junying [1 ]
Tong, Xinchun [1 ]
Lao, Julie [2 ]
Fong, Tung M. [2 ]
Schaeffer, Marie-Therese [2 ]
Xiao, Jing Chen [2 ]
Huang, Cathy C. R. -R. [2 ]
Shen, Chun-Pyn [2 ]
Stribling, D. Sloan [3 ]
Shearman, Lauren P. [3 ]
Strack, Alison M. [3 ]
MacIntyre, D. Euan [3 ]
Hale, Jeffrey J. [1 ]
Walsh, Thomas F. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA
关键词
Cannabinoid; CB1; Inverse agonist; Pyridopyrimidine; Obesity; CB1; 5,6-DIARYLPYRIDINES;
D O I
10.1016/j.bmcl.2009.03.005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, SAR and binding affinities are described for cannabinoid-1 receptor (CB1R) specific inverse agonists based on pyridopyrimidine and heterotricyclic scaffolds. Food intake and pharmacokinetic evaluation of several of these compounds indicate that they are effective orally active modulators of CB1R. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2591 / 2594
页数:4
相关论文
共 14 条
[1]  
[Anonymous], 2001, SURG GEN CALL ACT PR
[2]   Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[3]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725
[4]   Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists [J].
Debenham, JS ;
Madsen-Duggan, CB ;
Walsh, TF ;
Wang, JY ;
Tong, XC ;
Doss, GA ;
Lao, J ;
Fong, TM ;
Schaeffer, MT ;
Xiao, JC ;
Huang, CRRC ;
Shen, CP ;
Feng, Y ;
Marsh, DJ ;
Stribling, DS ;
Shearman, LP ;
Strack, AM ;
MacIntyre, DE ;
Van der Ploeg, LHT ;
Goulet, MT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) :681-685
[5]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134
[6]  
FELDER CC, 1995, MOL PHARMACOL, V48, P443
[7]   Early mortality among medicare beneficiaries undergoing bariatric surgical procedures [J].
Flum, DR ;
Salem, L ;
Elrod, JAB ;
Dellinger, EP ;
Cheadle, A ;
Chan, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (15) :1903-1908
[8]   Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents [J].
Fong, Tung M. ;
Guan, Xiao-Ming ;
Marsh, Donald J. ;
Shen, Chun-Pyn ;
Sloan Stribling, D. ;
Rosko, Kim M. ;
Lao, Julie ;
Yu, Hong ;
Feng, Yue ;
Xiao, Jing C. ;
Van der Ploeg, Lex H. T. ;
Goulet, Mark T. ;
Hagmann, Williams K. ;
Lin, Linus S. ;
Lanza, Thomas J., Jr. ;
Jewell, James P. ;
Liu, Ping ;
Shah, Shrenik K. ;
Qi, Hongbo ;
Tong, Xinchun ;
Wang, Junying ;
Xu, Suoyu S. ;
Francis, Barbara ;
Strack, Alison M. ;
MacIntyre, D. Euan ;
Shearman, Lauren P. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03) :1013-1022
[9]   CB1 cannabinoid antagonists:: Structure-activity relationships and potential therapeutic applications [J].
Jagerovic, Nadine ;
Fernandez-Fernandez, Cristina ;
Goya, Pilar .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (03) :205-230
[10]   Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists [J].
Madsen-Duggan, Christina B. ;
Debenham, John S. ;
Walsh, Thomas F. ;
Toupence, Richard B. ;
Huang, Song X. ;
Wang, Junying ;
Tong, Xinchun ;
Lao, Julie ;
Fong, Tung M. ;
Schaeffer, Marie-Therese ;
Xiao, Jing Chen ;
Huang, Cathy R-R. C. ;
Shen, Chun-Pyn ;
Stribling, D. Sloan ;
Shearman, Lauren P. ;
Strack, Alison M. ;
MacIntyre, D. Euan ;
Van der Ploeg, Lex H. T. ;
Goulet, Mark T. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :2031-2035